Bevacizumab in Glioblastoma — Still Much to Learn
This is an editorial in the New England Journal of Medicine in response to the reports on the 2 large trials of Avastin for newly diagnosed glioblastoma. These 2 trials both showed a small increase in progression free survival, but no increase in overall survival. However, the had opposite results in quality of life outcomes. Confusing, but the author brings up some good points on how to proceed from here.
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.nejm.org/doi/full/10.1056/NEJMe1313309
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines